John A. Tattory
CIK: 0001499834
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RNAZ
Transcode Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Tattory John A
Tattory John A (SEC CIK 0001499834) files insider reports with the SEC as Interim CFO of Transcode Therapeutics, Inc. (RNAZ).
Signal8 holds 1 ownership filing by Tattory John A, a Form 3, filed on Sep 21, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Tattory John A's filings is in BOSTON, MA.
Other insiders filing for Transcode Therapeutics, Inc. (RNAZ)
- Fitzgerald Thomas A, Chief Financial Officer
- DEFJ, LLC, 10% Owner
- CZEREPAK ELIZABETH, Director
- STOVER JACK E, Director